Marvell (MRVL -3.5%) is adding to the 11% decline it saw yesterday after Pittsburgh jury awarded Carnegie Mellon $1.17B in damages in a patent infringement suit against the chipmaker. Likely playing a role is a downgrade to Market Perform from JMP: the firm is worried about the impact of the verdict on Marvell's balance sheet, notes other lawsuits also exist, and (unsurprisingly) says checks indicate PC demand is soft.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Fri, 10:41AM)
at Nasdaq.com (Wed, 10:55AM)
at Benzinga.com (Feb 20, 2015)
at Benzinga.com (Feb 19, 2015)
at Nasdaq.com (Feb 5, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs